Annabelle J. Collins

Annabelle J. Collins

Auto-generated profile, based on publicly available information

Annabelle J. Collins

School of Chemical Sciences, The University of Auckland, Auckland 1142, New Zealand

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2020 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
BKBrooke X. C. Kwai
Brooke X. C. Kwai
ACAnnabelle J. Collins
Annabelle J. Collins
MMMartin J. Middleditch
Martin J. Middleditch
Jon SperryJon Sperry
Jon Sperry
GBGhader Bashiri
Ghader Bashiri
Ivanhoe LeungIvanhoe Leung
Ivanhoe Leung
Itaconate is a mammalian antimicrobial metabolite that inhibits the isocitrate lyases (ICLs) of Mycobacterium tuberculosis. Herein, we report that ICLs form a covalent adduct with itaconate through their catalytic cysteine residue. These results reveal atomic details of itaconate inhibition and provide insights into the catalytic mechanism of ICLs.

11 October 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
RBRam Bhusal
Ram Bhusal
WJWanting Jiao
Wanting Jiao
BKBrooke X. C. Kwai
Brooke X. C. Kwai
Johannes ReynissonJohannes Reynisson
Johannes Reynisson
ACAnnabelle J. Collins
Annabelle J. Collins
Ivanhoe LeungIvanhoe Leung
Ivanhoe Leung
Isocitrate lyase is important for lipid utilisation byMycobacterium tuberculosisbut its ICL2 isoform is poorly understood. Here we report that binding of the lipid metabolites acetyl-CoA or propionyl-CoA to ICL2 induces a striking structural rearrangement, substantially increasing isocitrate lyase and methylisocitrate lyase activities. Thus, ICL2 plays a pivotal role regulating carbon flux between the tricarboxylic acid (TCA) cycle, glyoxylate shunt and methylcitrate cycle at high lipid concentrations, a mechanism essential for bacterial growth and virulence.